Pharmedic Pharmaceutical Medicinal JSC (HNX:PMC)

Market Cap	1.33T +23.2%
Revenue (ttm)	546.57B +9.7%
Net Income	82.30B +2.7%
EPS	8,819.10 +40.7%
Shares Out	9.33M
PE Ratio	16.20
Forward PE	n/a
Dividend	2,400.00 (1.68%)
Ex-Dividend Date	Nov 21, 2025

Volume	1,105
Average Volume	75,009
Open	143,000
Previous Close	130,000
Day's Range	121,500 - 143,000
52-Week Range	100,200 - 189,000
Beta	-0.36
RSI	48.09
Earnings Date	Apr 17, 2026

About HNX:PMC

Pharmedic Pharmaceutical Medicinal Joint Stock Company engages in the manufacture and trade of pharmaceutical products, medicinal materials, cosmetics, medical supplies, and other products in Vietnam. The company offers non-prescription drug products for gastrointestinal and hepatobiliary; cardiovascular; respiratory; central nervous; skeletal; hormones; anti-infectives; urinary; endocrine and metabolic; vitamins and minerals; eye; ear – mouth/ throat; dermatologicals; allergy and immune; cardiovascular; diabetes; and other systems. It also pro...

• Industry: Pharmaceutical Preparations
• Founded: 1981
• Employees: 535
• Stock Exchange: Hanoi Stock Exchange
• Ticker Symbol: PMC

Financial Performance

In 2025, HNX:PMC's revenue was 546.57 billion, an increase of 9.71% compared to the previous year's 498.18 billion. Earnings were 82.30 billion, an increase of 40.70%.